etrials and Omnicare Clinical Research Sign Licensing Agreement
Multi-Year Subscription to Simplify and Accelerate Clinical Trial Research
Morrisville, NC--April 25, 2005--etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, announced today that Omnicare Clinical Research, a subsidiary of Omnicare, Inc. and provider of drug development services to pharmaceutical, biotechnology and medical device companies, has signed a multi-year, subscription licensing agreement that will enable its clients to utilize etrials' eClinical platform for collecting, monitoring and analyzing clinical trial data.
Using these tools, Omnicare will develop and tailor studies for its clients to improve patient enrollment, provide access to cleaner data faster and shorten study timelines. etrials' easy-to-use, fully integrated technologies will help meet the eClinical needs of Omnicare's clients who conduct clinical trials of all sizes and complexities in a wide variety of therapeutic areas. To date, the companies have already begun work on two studies utilizing etrials' eClinical Suite of products.
"Progressive CROs like Omnicare have continued to try and distinguish themselves in the market by seeking out the best new technology offerings for their clients. By offering tools to expedite data collection and ultimately their clients' trials, Omnicare is ahead of the curve," said John Cline, CEO of etrials. "Our first cooperative trial with Omnicare, which is for a top-ten pharmaceutical company, serves as an example that the industry now recognizes the importance of eClinical technologies in trial research."
About etrials Worldwide, Inc.
etrials is a software and services company dedicated to making eClinical easy. We are the first company to offer a fully integrated suite of eClinical software including electronic data capture (EDC), electronic patient reported outcomes (ePRO), interactive voice response (IVR) and analytics to support the entire clinical trial process, from collection and cleaning to the integration and review of data. Our expertise includes studies from Phase I to post-approval for pharmaceutical, biotechnology and clinical research organizations. To date, our team of professionals has participated in over 450 clinical trials in more than 50 different countries.
etrials makes easy-to-use technologies supported by people who are just as easy to work with. Visit us at www.etrials.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
